2 recruiting, 1 active not recruiting, 1 completed, 1 enrolling by invitation. 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow BlueRock Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease bemdaneprocel, Sham surgery - Parkinsons Disease (PD) | Phase 3 | Recruiting | BlueRock Therapeutics | 102 | 2025-06-17 | 2026-08-04 |
| A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) OpCT-001 - Primary Photoreceptor Disease, Retinitis Pigmentosa (RP) | Phase 1 / Phase 2 | Recruiting | BlueRock Therapeutics | 54 | 2025-03-10 | 2026-10-15 |
| Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01 Parkinson Disease | Enrolling by invitation | BlueRock Therapeutics | 12 | 2023-05-16 | 2024-04-12 | |
| Noninterventional Study Evaluating Parkinson's Disease Diary Use Parkinson's Disease | Active not recruiting | BlueRock Therapeutics | 194 | 2022-07-29 | 2024-07-31 | |
| Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease MSK-DA01, MSK-DA01 Cell Delivery Device - Advanced Parkinson's Disease | Phase 1 | Completed | BlueRock Therapeutics | 12 | 2021-05-03 | 2024-11-01 |
Parkinson Disease (3) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cone-Rod Dystrophies (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Parkinsonian Disorders (1) · Retinal Degeneration (1) · Retinitis Pigmentosa (1) · Synucleinopathies (1) · Usher Syndromes (1)
United States (5) · Canada (4) · Australia (1) · Germany (1) · Italy (1) · Spain (1)
Nauman Abid, MD (1)